CpG motifs in bacterial DNA trigger direct B-cell activation
- 1 April 1995
- journal article
- letter
- Published by Springer Nature in Nature
- Vol. 374 (6522), 546-549
- https://doi.org/10.1038/374546a0
Abstract
UNMETHYLATED CpG dinucleotides are more frequent in the gen-omes of bacteria and viruses than of vertebrates. We report here that bacterial DNA and synthetic oligodeoxynucleotides containing unmethylated CpG dinucleotides induce murine B cells to proliferate and secrete immunoglobulin in vitro and in vivo. This activation is enhanced by simultaneous signals delivered through the antigen receptor. Optimal B-cell activation requires a DNA motif in which an unmethylated CpG dinucleotide is flanked by two 5' purines and two 3' pyrimidines. Oligodeoxynucleotides containing this CpG motif induce more than 95% of all spleen B cells to enter the cell cycle. These data suggest a possible evolutionary link between immune defence based on the recognition of microbial DNA and the phenomenon of 'CpG suppression' in vertebrates. The potent immune activation by CpG oligonucleotides has impli-cations for the design and interpretation of studies using 'antisense' oligonucleotides and points to possible new applications as adjuvants.Keywords
This publication has 28 references indexed in Scilit:
- Gene inhibition using antisense oligodeoxynucleotidesNature, 1994
- Subversion of the immune system by pathogensCell, 1994
- Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?Science, 1993
- Current concepts in antisense drug designJournal of Medicinal Chemistry, 1993
- Therapeutic Applications of OligonucleotidesAnnual Review of Pharmacology and Toxicology, 1992
- Evidence for impaired t cell dna methylation in systemic lupus erythematosus and rheumatoid arthritisArthritis & Rheumatism, 1990
- CpG islands as gene markers in the vertebrate nucleusTrends in Genetics, 1987
- DNA binding to human leukocytes. Evidence for a receptor-mediated association, internalization, and degradation of DNA.Journal of Clinical Investigation, 1985
- Frequency of B lymphocytes responsive to anti-immunoglobulin.The Journal of Experimental Medicine, 1982
- B cell helper factors. I. Requirement for both interleukin 2 and another 40,000 mol wt factor.The Journal of Experimental Medicine, 1981